US Stock MarketDetailed Quotes

OMIC Singular Genomics

Watchlist
  • 13.320
  • +0.320+2.46%
Close Oct 31 16:00 ET
33.24MMarket Cap-357P/E (TTM)

Singular Genomics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
45.94%737K
-48.78%442K
280.52%2.91M
41.31%1.08M
462K
505K
863K
765K
765K
0
Operating revenue
45.94%737K
-48.78%442K
280.52%2.91M
41.31%1.08M
--462K
--505K
--863K
--765K
--765K
--0
Cost of revenue
53.27%915K
6.69%861K
339.67%3.47M
94.93%1.54M
527K
597K
807K
789K
789K
0
Gross profit
-93.48%-178K
-848.21%-419K
-2,225.00%-558K
-1,804.17%-457K
-65K
-92K
56K
-24K
-24K
0
Operating expense
-17.76%22.63M
3.91%26.43M
9.39%102.24M
10.30%24.82M
-0.89%24.47M
13.48%27.51M
15.50%25.43M
52.52%93.46M
14.40%22.51M
41.42%24.69M
Selling and administrative expenses
-20.08%11.9M
13.11%14.94M
15.27%54.48M
11.82%13.13M
10.80%13.25M
22.20%14.89M
16.08%13.2M
65.12%47.26M
14.95%11.75M
39.89%11.96M
Research and development costs
-15.02%10.73M
-6.02%11.49M
3.39%47.76M
8.64%11.69M
-11.88%11.22M
4.67%12.62M
14.89%12.23M
41.48%46.2M
13.80%10.76M
42.90%12.73M
Operating profit
17.39%-22.8M
-5.79%-26.85M
-9.96%-102.8M
-12.21%-25.28M
0.63%-24.54M
-13.86%-27.6M
-15.25%-25.38M
-52.56%-93.49M
-14.52%-22.53M
-41.42%-24.69M
Net non-operating interest income expense
-23.46%1.55M
4.53%1.82M
206.02%7.98M
42.20%2.03M
141.04%2.18M
675.86%2.03M
12,364.29%1.75M
2,407.96%2.61M
1,742.53%1.43M
702.67%904K
Non-operating interest income
-20.00%1.84M
5.19%2.11M
169.42%9.08M
38.70%2.32M
120.99%2.46M
436.21%2.3M
1,184.62%2M
359.89%3.37M
1,492.38%1.67M
1,227.38%1.12M
Non-operating interest expense
5.93%286K
9.65%284K
44.30%1.1M
18.11%287K
35.07%285K
61.68%270K
82.39%259K
-9.81%763K
26.56%243K
-9.83%211K
Other net income (expense)
Income before tax
16.91%-21.25M
-5.89%-25.02M
-4.34%-94.82M
-10.18%-23.25M
6.01%-22.36M
-6.65%-25.58M
-7.39%-23.63M
7.99%-90.88M
-6.79%-21.1M
-35.09%-23.79M
Income tax
Net income
16.91%-21.25M
-5.89%-25.02M
-4.34%-94.82M
-10.18%-23.25M
6.01%-22.36M
-6.65%-25.58M
-7.39%-23.63M
7.99%-90.88M
-6.79%-21.1M
-35.09%-23.79M
Net income continuous Operations
16.91%-21.25M
-5.89%-25.02M
-4.34%-94.82M
-10.18%-23.25M
6.01%-22.36M
-6.65%-25.58M
-7.39%-23.63M
7.99%-90.88M
-6.79%-21.1M
-35.09%-23.79M
Minority interest income
Net income attributable to the parent company
16.91%-21.25M
-5.89%-25.02M
-4.34%-94.82M
-10.18%-23.25M
6.01%-22.36M
-6.65%-25.58M
-7.39%-23.63M
7.99%-90.88M
-6.79%-21.1M
-35.09%-23.79M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
16.91%-21.25M
-5.89%-25.02M
-4.34%-94.82M
-10.18%-23.25M
6.01%-22.36M
-6.65%-25.58M
-7.39%-23.63M
7.99%-90.88M
-6.79%-21.1M
-35.09%-23.79M
Basic earnings per share
19.00%-8.57
-3.03%-10.2
-1.56%-39
-6.90%-9.3
6.06%-9.3
-3.73%-10.58
-6.45%-9.9
39.05%-38.4
-7.41%-8.7
-32.00%-9.9
Diluted earnings per share
19.00%-8.57
-3.03%-10.2
-1.56%-39
-6.90%-9.3
6.06%-9.3
-3.73%-10.58
-6.45%-9.9
39.05%-38.4
-7.41%-8.7
-32.00%-9.9
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 45.94%737K-48.78%442K280.52%2.91M41.31%1.08M462K505K863K765K765K0
Operating revenue 45.94%737K-48.78%442K280.52%2.91M41.31%1.08M--462K--505K--863K--765K--765K--0
Cost of revenue 53.27%915K6.69%861K339.67%3.47M94.93%1.54M527K597K807K789K789K0
Gross profit -93.48%-178K-848.21%-419K-2,225.00%-558K-1,804.17%-457K-65K-92K56K-24K-24K0
Operating expense -17.76%22.63M3.91%26.43M9.39%102.24M10.30%24.82M-0.89%24.47M13.48%27.51M15.50%25.43M52.52%93.46M14.40%22.51M41.42%24.69M
Selling and administrative expenses -20.08%11.9M13.11%14.94M15.27%54.48M11.82%13.13M10.80%13.25M22.20%14.89M16.08%13.2M65.12%47.26M14.95%11.75M39.89%11.96M
Research and development costs -15.02%10.73M-6.02%11.49M3.39%47.76M8.64%11.69M-11.88%11.22M4.67%12.62M14.89%12.23M41.48%46.2M13.80%10.76M42.90%12.73M
Operating profit 17.39%-22.8M-5.79%-26.85M-9.96%-102.8M-12.21%-25.28M0.63%-24.54M-13.86%-27.6M-15.25%-25.38M-52.56%-93.49M-14.52%-22.53M-41.42%-24.69M
Net non-operating interest income expense -23.46%1.55M4.53%1.82M206.02%7.98M42.20%2.03M141.04%2.18M675.86%2.03M12,364.29%1.75M2,407.96%2.61M1,742.53%1.43M702.67%904K
Non-operating interest income -20.00%1.84M5.19%2.11M169.42%9.08M38.70%2.32M120.99%2.46M436.21%2.3M1,184.62%2M359.89%3.37M1,492.38%1.67M1,227.38%1.12M
Non-operating interest expense 5.93%286K9.65%284K44.30%1.1M18.11%287K35.07%285K61.68%270K82.39%259K-9.81%763K26.56%243K-9.83%211K
Other net income (expense)
Income before tax 16.91%-21.25M-5.89%-25.02M-4.34%-94.82M-10.18%-23.25M6.01%-22.36M-6.65%-25.58M-7.39%-23.63M7.99%-90.88M-6.79%-21.1M-35.09%-23.79M
Income tax
Net income 16.91%-21.25M-5.89%-25.02M-4.34%-94.82M-10.18%-23.25M6.01%-22.36M-6.65%-25.58M-7.39%-23.63M7.99%-90.88M-6.79%-21.1M-35.09%-23.79M
Net income continuous Operations 16.91%-21.25M-5.89%-25.02M-4.34%-94.82M-10.18%-23.25M6.01%-22.36M-6.65%-25.58M-7.39%-23.63M7.99%-90.88M-6.79%-21.1M-35.09%-23.79M
Minority interest income
Net income attributable to the parent company 16.91%-21.25M-5.89%-25.02M-4.34%-94.82M-10.18%-23.25M6.01%-22.36M-6.65%-25.58M-7.39%-23.63M7.99%-90.88M-6.79%-21.1M-35.09%-23.79M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 16.91%-21.25M-5.89%-25.02M-4.34%-94.82M-10.18%-23.25M6.01%-22.36M-6.65%-25.58M-7.39%-23.63M7.99%-90.88M-6.79%-21.1M-35.09%-23.79M
Basic earnings per share 19.00%-8.57-3.03%-10.2-1.56%-39-6.90%-9.36.06%-9.3-3.73%-10.58-6.45%-9.939.05%-38.4-7.41%-8.7-32.00%-9.9
Diluted earnings per share 19.00%-8.57-3.03%-10.2-1.56%-39-6.90%-9.36.06%-9.3-3.73%-10.58-6.45%-9.939.05%-38.4-7.41%-8.7-32.00%-9.9
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data